Literature DB >> 14757434

Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation.

Yuchang Fu1, Lidia Maianu, Barry R Melbert, W Timothy Garvey.   

Abstract

Cellular glucose uptake is mediated by a family of facilitative glucose transporters (GLUT) exhibiting differences in kinetics, substrate specificity, and tissue-specific expression. GLUT isoform expression has not been comprehensively studied in human leukocytes, which participate in immune and inflammatory responses and are critical for host defense. Therefore, we studied the regulated expression of GLUT 1-5 mRNA and protein in isolated human lymphocytes and monocytes and in human THP-1 macrophages and foam cells. Lymphocytes expressed GLUT 1 and GLUT 3 proteins, and cellular levels of both isoforms were augmented 3.5- to 6-fold following activation by phytohemagglutinin (PHA). Monocytes expressed 8.4-fold more GLUT 3 protein and 88% less GLUT 1 than lymphocytes, and activation by lipopolysaccharide (LPS) led to a 1.9-fold increase in GLUT 1. At the level of mRNA expression, GLUT 3 mRNA was the most prevalent GLUT mRNA species in monocytes, while lymphocytes expressed equal numbers of GLUT 1 and GLUT 3 transcripts. Differentiation of THP-1 monocytes into macrophages was associated with marked induction of GLUT 3 and GLUT 5 protein expression, and high levels of GLUT 1, GLUT 3, and GLUT 5 were maintained after transformation to foam cells. GLUT 5 mRNA was expressed in 2-fold greater abundance in macrophages and foam cells than that observed for GLUT 1 mRNA, while the level of GLUT 3 mRNA was intermediate. This facilitative glucose transporters are differentially expressed and regulated in human leukocytes in a pattern that could facilitate cellular functions. Speculatively, high GLUT 1 and GLUT 3 expression could provide cellular fuel for the immune response, and high levels of high-affinity GLUT 3 in macrophages might allow the cell to compete with pathogens for hexoses, even in the presence of low interstitial glucose concentrations. Ample expression of GLUT 1 and GLUT 3 in foam cells could also provide hexose substrates and promote lipid loading. The role for high levels of the fructose transporter GLUT 5 in macrophages and foam cells is unknown since interstitial and circulating fructose concentrations are low in these cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757434     DOI: 10.1016/j.bcmd.2003.09.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  65 in total

1.  Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages.

Authors:  Aramati B M Reddy; Satish K Srivastava; Kota V Ramana
Journal:  Int J Biochem Cell Biol       Date:  2010-03-27       Impact factor: 5.085

2.  Persistent glucose transporter expression on pancreatic beta cells from longstanding type 1 diabetic individuals.

Authors:  Ken T Coppieters; Anna Wiberg; Natalie Amirian; Thomas W Kay; Matthias G von Herrath
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

Review 3.  The facilitative glucose transporter GLUT3: 20 years of distinction.

Authors:  Ian A Simpson; Donard Dwyer; Daniela Malide; Kelle H Moley; Alexander Travis; Susan J Vannucci
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

Review 4.  Even low-grade inflammation impacts on small intestinal function.

Authors:  Katri Peuhkuri; Heikki Vapaatalo; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 5.  Functional imaging of infection: conventional nuclear medicine agents and the expanding role of 18-F-FDG PET.

Authors:  Marguerite T Parisi
Journal:  Pediatr Radiol       Date:  2011-05-24

6.  Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Authors:  Laurent Dercle; Roland Chisin; Samy Ammari; Quentin Gillebert; Monia Ouali; Cyril Jaudet; Jean-Pierre Delord; Lawrence Dierickx; Slimane Zerdoud; Martin Schlumberger; Frédéric Courbon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-01       Impact factor: 9.236

Review 7.  Diabetic vascular disease and the potential role of macrophage glucose metabolism.

Authors:  Tomohiro Nishizawa; Karin E Bornfeldt
Journal:  Ann Med       Date:  2011-06-17       Impact factor: 4.709

8.  ¹⁸F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis.

Authors:  Damien Mandry; Alexis Tatopoulos; Elodie Chevalier-Mathias; Jérémie Lemarié; Pierre-Edouard Bollaert; Véronique Roch; Pierre Olivier; Pierre-Yves Marie; Sébastien Gibot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-22       Impact factor: 9.236

9.  Insulin effect on glucose transport in thymocytes and splenocytes from rats with metabolic syndrome.

Authors:  Roxana Carbó; Verónica Guarner
Journal:  Diabetol Metab Syndr       Date:  2010-11-02       Impact factor: 3.320

10.  Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.

Authors:  Anastasia Murat; Eugenia Migliavacca; S Farzana Hussain; Amy B Heimberger; Isabelle Desbaillets; Marie-France Hamou; Curzio Rüegg; Roger Stupp; Mauro Delorenzi; Monika E Hegi
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.